The diagnosis and management of gastric cancer: Expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010

Cutsem, E. van; Dicato, M.; Geva, R.; Arber, N.; Bang, Y.; Benson, A.; Cervantes, A.; Diaz-Rubio, E.; Ducreux, M.; Glynne-Jones, R.; Grothey, Axel; Haller, D.; Haustermans, K.; Kerr, D.; Nordlinger, B.; Marshall, J.; Minsky, B. D.; Kang, Y. K.; Labianca, R.; Lordick, F.; Ohtsu, A.; Pavlidis, Nicholas; Roth, A.; Rougier, P.; Schmoll, H. J.; Sobrero, A.; Tabernero, Josep; Velde, C. van de; Zalcberg, J.

doi:10.1093/annonc/mdr284

Article

Date

2011

Author

Cutsem, E. van
Dicato, M.
Geva, R.
Arber, N.
Bang, Y.
Benson, A.
Cervantes, A.
Diaz-Rubio, E.
Ducreux, M.
Glynne-Jones, R.
Grothey, Axel
Haller, D.
Haustermans, K.
Kerr, D.
Nordlinger, B.
Marshall, J.
Minsky, B. D.
Kang, Y. K.
Labianca, R.
Lordick, F.
Ohtsu, A.

Pavlidis, Nicholas
Roth, A.
Rougier, P.
Schmoll, H. J.
Sobrero, A.
Tabernero, Josep
Velde, C. van de
Zalcberg, J.

Source

Annals of Oncology

Volume

Issue

SUPPL. 5

Pages

v1-v9

Google Scholar check

Keyword(s):

Human

Humans

Computer assisted tomography

Meta analysis (topic)

Genetic predisposition to disease

Cancer adjuvant therapy

Placebo

Nuclear magnetic resonance imaging

Drug dose reduction

Bevacizumab

Gimeracil plus oteracil potassium plus tegafur

Fluorodeoxyglucose f 18

Positron emission tomography

Carcinoembryonic antigen

Infection control

Caloric intake

Capecitabine

Phase 3 clinical trial (topic)

Primary tumor

Metastasis potential

Practice guidelines as topic

Ca 19-9 antigen

Computer assisted radiotherapy

Cyanocobalamin

Folic acid

Cancer susceptibility

Endoscopic echography

Endoscopic mucosal resection

Esophageal adenocarcinoma

Helicobacter infection

Helicobacter pylori

Intensity modulated radiation therapy

Lower esophagus sphincter

Stomach adenocarcinoma

Metadata

Show full item record

Abstract

Well-recognized experts in the field of gastric cancer discussed during the 12th European Society Medical Oncology (ESMO)/World Congress Gastrointestinal Cancer (WCGIC) in Barcelona many important and controversial topics on the diagnosis and management of patients with gastric cancer. This article summarizes the recommendations and expert opinion on gastric cancer. It discusses and reflects on the regional differences in the incidence and care of gastric cancer, the definition of gastro-esophageal junction and its implication for treatment strategies and presents the latest recommendations in the staging and treatment of primary and metastatic gastric cancer. Recognition is given to the need for larger and well-designed clinical trials to answer many open questions. © The Author 2011. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.